A BSA complex with 13(Z)-docosenoic acid
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BSA-13(Z)-Docosenoate Monounsaturated Fatty Acid Complex (1 mM)

Item No. 39150

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • Bovine Serum Albumin-13(Z)-Docosenoate
  • BSA-Erucate
Formulation (Request formulation change)
1 mM 13(Z)-docosenoate:0.17 mM BSA in 150 mM sodium chloride, pH 7.4
Origin
Animal/Bovine
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 ml

    $110

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    BSA-13(Z)-Docosenoate Monounsaturated Fatty Acid Complex (1 mM) is composed of 13(Z)-docosenoic acid (Item Nos. 90175) and fatty acid-free bovine serum albumin (BSA) at an approximately 6:1 molar ratio of 13(Z)-docosenoate:BSA. It can be used for efficient fatty acid delivery to cells in culture for the purpose of monitoring lipid metabolism, including fatty acid oxidation, and inflammatory signaling pathways.1,2 It can also be used to study the effect of 13(Z)-docosenoic acid on cardiac electrophysiology and myocardial lipidosis.3,4 Cayman’s BSA-13(Z)-Docosenoate Monounsaturated Fatty Acid Complex (1 mM) is suitable for use in short-term cell culture applications (acute treatment to 18 hours); however, for long-term applications (25+ hours) the product should be filter-sterilized using a 0.2 µm filter and sterile receptacle, which will not affect its performance. For best results, it is recommended that this product be used in conjunction with Cayman’s BSA Control for BSA-Fatty Acid Complexes (1 mM) (Item No. 34932), prepared with fatty acid-free BSA.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Alsabeeh, N., Chausse, B., Kakimoto, P.A., et al. Cell culture models of fatty acid overload: Problems and solutions. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1863(2), 143-151 (2018).

    2. Clouet, P., and Bezard, J. In vitro conversion of erucic acid by microsomes and mitochondria from liver, kidneys and heart of rats. Lipids 14(3), 268-273 (1978).

    3. Athias, P., Pinson, A., Frelin, C., et al. Comparative study on the effects of exogenous palmitate and erucate on intracellular electric properties of cultured beating heart cells. J. Mol. Cell. Cardiol. 11(8), 755-767 (1979).

    4. Zhang, M., Wang, Q., Wang, X., et al. Erucic acid aggravates cardiac fibrosis after myocardial infarction by CD36-mediated metabolic reprogramming with impaired mitochondrial aerobic oxidation. Cell Signal. 146, 112636 (2026).